Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD
Research output: Contribution to journal › Journal article › Research
Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening.
Original language | English |
---|---|
Journal | PloS one |
Volume | 8 |
Issue number | 10 |
Pages (from-to) | e76990 |
ISSN | 1932-6203 |
DOIs | |
Publication status | Published - 2013 |
ID: 94618407